FDA Approved: BUPRENORPHINE AND NALOXONE — Original Application (Dr.Reddys Laboratories Inc)

View source ↗

Summary

FDA approved Dr. Reddy's Laboratories' buprenorphine and naloxone generic combination for the treatment of opioid dependence (ANDA 205299).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Buprenorphine and naloxone (BUPRENORPHINE AND NALOXONE)

Snippet

ORIG AP for BUPRENORPHINE AND NALOXONE (BUPRENORPHINE AND NALOXONE)